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In Switzerland, the mortality rate 
due to influenza infection has 
been estimated at more than 1000 
deaths ayear based on death certifi- 
cates 1,2. The average mortality rate 
due to influenza is underreported 
and it might be assumed to be four 
times higher than the official death 
declarations [Claude Hannoun, 
personal communication] as the 
death certificates document only 
the major causes of death and not 
any underlying conditions 3 
Influenza vaccination has been 
shown to be efficacious and effi- 
cient in preventing infection in the 
population, providing considerable 
financial savings due to fewer epi- 
sodes of upper respiratory tract 
infection and fewer visits to the 
physician. For high risk groups, the 
vaccination reduces the frequency 
of hospitalizations and the mor- 
tality 4-6. Nevertheless, there is no 
uniformity in the definitions of risk 
groups and recommendations on
who should receive the vaccine vary 
between different countries 7.
Within Western Europe, there are 
differences in the recommenda- 
tions for the elderlyT; in Belgium 
it is recommended for people over 
60 years, in Switzerland for those 
over 65 years, in France for those 
more than 70 years of age whereas 
the United Kingdom decided for 
the first time in 1998 to recommend 
vaccination for elderly people who 
are more than 75 years old 8. In all 
countries there are recommenda- 
tions to vaccinate persons at high 
risk for influenza such as those with 
chronic heart, lung or kidney dis- 
ease, diabetes or other serious ill- 
nesses 9.
Within Western Europe, Switzer- 
land has one of the lowest influenza 
vaccination coverage rates with an 
estimated 75 doses of vaccine dis- 
tributed per 1000 total population 
in 1997, and 100 doses in 1998. This 
figure does not mean that all doses 
of vaccine distributed are actually 
administered, nor does it mean that 
all doses given are received by 
persons for whom vaccination is 
specifically recommended. 
The Swiss Federal Office of Public 
Health (SFOPH) publishes annual 
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recommendations on the vaccina- 
tion against influenza 1. However, 
the health authorities of the 23 can- 
tons are free to organize and pro- 
mote vaccination programmes lo- 
cally. This leads to an inconsistent 
promotion within the country. In 
1997/98, influenza vaccination was 
recommended forindividuals older 
than 65 years, for adults and child- 
ren with cardiac or pulmonary 
pathologies, for residents of homes 
and health institutions, and for 
patients with chronic diseases; for 
all persons in these groups the 
medical insurance companies gua- 
rantee reimbursement for the cost 
of vaccination. The medical staff 
and personnel of health care in- 
stitutions as well as family and 
contacts of individuals at risk are 
also recommended for vaccination 
but no reimbursement is provided 
by the insurance companies. 
This study was conducted in June 
1998 to collect information on 
influenza vaccination coverage and 
promotion practices. Another 
objective was to discover which 
promotional support would be 
most effective in encouraging the 
application of influenza vaccina- 
tion within health care institutions 
(not shown here). 
Material and Methods 
Institutions 
In June 1998 a questionnaire was 
sent o 429 Swiss health care institu- 
tions. They were selected through a
private association which provides 
statistical and accounting services 
to the major health care providers 
in the country. All members of 
this association were contacted for 
the survey. This systematic samp- 
ling included university and gene- 
ral hospitals (51%), maternity and 
children's hospitals (8 %), rehabili- 
tation clinics (10%), retirement 
and nursing homes (21%) and psy- 
chiatric clinics (10%) (Table 1). 
These enrolled institutions account 
for 15% (429/2882) of all health 
care institutions in Switzerland. 
Questionnaire 
The questionnaire was sent to each 
institution itself, not to a specific 
addressee. It was first written in 
French and then translated into 
German and Italian. Overall, 299 
institutions received the question- 
naire in German, 101 in French and 
29 in Italian. The analysis eparates 
the data collected in the three lin- 
guistic regions. The cut-off time for 
reply was one month, no reminders 
were issued. 
The first part of the questionnaire 
concerned the level of influenza 
vaccination within the institution 
with emphasis on the vaccination 
coverage within specified groups 
(total residents/patients; patients 
older than 65 years; all staff, in- 
cluding paramedical nd adminis- 
trative as well as technical staff, 
and medical staff alone). The re- 
spondent was requested to specify 
whether vaccination coverage had 
been measured using records of 
doses administered, or whether a 
less precise method of estimation 
had been used. 
The second part of the question- 
naire dealt with specific actions 
to promote influenza vaccination 
within an institution. The respon- 
dent's opinions on the most useful 
means and support required to 
promote influenza vaccination in 
case of a national campaign, and 
who should play the principal role 
in a vaccination programme were 
also requested (results not shown 
here). The questionnaire was pilot- 
tested on a small group of profes- 
sionals selected from public and 
private health institutions. 
Type of institution 
Hospital with > 124 beds 
Psychiatric linic 
C 
Retirement home, geriatric linic 
Total 
87 45 
44 22 
4I 20 
92 37 
132 48 
33 10 
429 182 
Table 1. Health institutions involved in the survey and response rates, Switzerland, 1998 (ranked by response rate). 
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Statistics 
The analysis of data was performed 
at the Institute of Social and Pre- 
ventive Medicine in Geneva using 
SPSS software version 6.0 for Win- 
dows. Data is summarized using 
means and ranges. Means were cal- 
culated without weighting by size 
of institution. 
Results 
429 (14.9%) of the existing 2882 
Swiss health care institutions were 
included in this survey. The re- 
sponse rate was 42.4% (182/429) 
and varied according to the type 
of institution (Table 1). 
Respondents from all institutions 
were asked to provide the precise 
rate of vaccination coverage of the 
different risk groups, if known. 
Otherwise, they were asked to 
provide an estimate or to state that 
no reply was possible (Table 2). 
This information was obtained for 
each or the four groups: all pa- 
tients/residents; elderly residents; 
all institution staff; and medical 
staff. Overall, 40% of all insti- 
tutions were unable to provide 
any data on the vaccination rates 
of their patients, residents or em- 
ployees. 
The precise vaccination coverage 
rates for all patients and residents 
ranged from 0 to 100% with a 
mean of 40 %; where the rate was 
estimated the mean was 29% 
(Table 3). These rates were slightly 
higher for elderly people (47% 
known and 37 % estimated cover- 
age). With regard to the entire in- 
stitution staff, the mean precisely 
known immunization rate was 16 % 
(0-100%) but only 14% (0-80%) 
where estimated. These numbers 
were slightly higher for medical 
staff, where 30% (0-100%) were 
known to have been vaccinated 
against influenza and 16% (0- 
80 %) were estimated to have been 
vaccinated. 
Table 2. Proportion of health institutions providing measured, estimated 
or no data on vaccination coverage of risk groups (N = 182), Switzerland, 
1998. 
Table 3. Measured and estimated vaccination coverage rate (mean and 
range) of risk groups, Switzerland, 1998. 
Table 4. Vaccination coverage (mean and range) for institution returning 
measured data, for two risk groups, according to the linguistic regions of 
Switzerland, 1998. 
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The responses were also evaluated 
according to the three major lingu- 
istic regions of Switzerland (Table 
4). The mean vaccination rate for 
patients and residents was highest 
in the French speaking region 
(59%), and almost as high as in 
the Italian speaking canton (54 %), 
whereas in the German speaking 
region it was lower (37 %). Similar 
findings were obtained for vaccina- 
tion coverage of the medical staff: 
21% in the French speaking re- 
gion, 15 % in the Italian speaking 
canton and 13% in the German 
speaking region. 
Discussion 
The relatively low response rate 
of 42.4 % may be explained by the 
facts that no reminder was sent, 
questionnaires were sent outside 
the vaccination period, shortly 
before a holiday period, and with- 
out a specific addressee. No in- 
formation is available concerning 
the non-respondents. The lower 
response rates in the children's and 
mothercare clinics may be due to 
the fact that the management of
such institutions has little concern 
about this vaccination ~,9. The high 
response rates in large hospitals 
and psychiatric linics may reflect 
a concern with influenza vaccina- 
tion due to the presence in these 
institutions of patients of all risk 
groups. 
The mean estimated rates for vac- 
cination coverage were generally 
lower than the precisely known 
rates. The differences varied be- 
tween 14% for the medical staff, 
11% for the residents and 10% 
for the elderly; but this was not 
true for the entire staff where 
the mean estimated rate was only 
2 % lower than the measured rates 
(Table 3). This difference may be 
related to a reputation of useless- 
ness and lack of efficiency of the 
influenza vaccination within the 
medical institutional environment. 
The highest precisely known mean 
vaccination rates were found for the 
elderly (47%) and the residents- 
patients (40%). The SFOPH re- 
commends vaccination for these 
groups, while the staff is eligible 
for vaccination but not con- 
sidered a risk group. The cost of 
the vaccine is not reimbursed by 
the medical insurance for the 
employees of health institutions, a 
fact which might contribute to the 
underestimation of the coverage as 
well as the low vaccination rate. 
Nevertheless, these rates are low in 
comparison with studies in other 
countries. Nichol found that im- 
munization rates in the United 
States among high risk patients can 
be increased from 58% to 84% 
with a good vaccination program 10. 
In comparison, vaccination cover- 
age for the elderly with high risk 
conditions discharged from hos- 
pitals is reported to be at 68 % in 
the United Kingdom 11 and about 
70 % in France 12. 
For patients and residents, the mean 
rates were very low, particularly as 
it has been shown that the vaccina- 
tion of health care workers had 
important beneficial effects on pa- 
tient mortality and frequency of 
influenza-like illness 13. Other stu- 
dies confirmed that the vaccination 
of health workers reduces febrile 
respiratory illness and reported 
days of work absence 14, is 
With regard to the staff, either all 
employees or only medical per- 
sonnel, the measured and estimat- 
ed rates for influenza vaccination 
coverage were much lower than for 
the other groups, potentially reflect- 
ing little interest in protecting the 
staff or a possible resistance toward 
this preventive measure. 
The results also demonstrate hat 
the perception of public health 
measures differs between the three 
linguistic regions. The differences 
among the three regions appeared 
strongly also in the Swiss Health 
Survey. For the total population 
the number of persons vaccinated 
within the last two years preceding 
the survey (vaccinated in 1996 
and/or 1997) are 17.8% in the 
French speaking area, 11.2% in 
the Italian speaking canton, and 
9.7% for German speaking Swit- 
zerland 16. The 1996 coverage in 
Switzerland is 6.1%, for compari- 
son in the neighbouring countries 
based on the number of sold doses, 
the rates are 15.0 % for Italy, 13.4 % 
for France, 9.2 % for Germany and 
6.1% for Austria [David Fedson, 
Fred Ambrosch, personal commu- 
nication]. One can suggest that this 
may be due to a tendency for a 
similar identity as well as cultural 
influence from the neighbouring 
country speaking the same langu- 
age. France has been very active in 
promoting influenza vaccination 
for nearly 20 years and the impact 
of this media campaign has been 
felt throughout the French speak- 
ing part of Switzerland. Germany 
and Austria show a low vaccination 
coverage, and some German speak- 
ing cantons are the home for anti- 
vaccination activist movements; 
especially the Swiss Germans eem 
to favour more natural preventive 
measures and tend to reject im- 
munisations. The coverage rate for 
the Italian speaking canton can- 
not be compared with the Italian 
national rate, unfortunately specif- 
ic data for the Italian autonomous 
regions bordering Ticino are not 
available. 
Conclusion 
This study has shown that in 
Switzerland, where no national 
influenza vaccination programme 
exists, knowledge of health institu- 
tions on vaccination rates either of 
their patients or their employees i  
sparse and uncertain. When pre- 
cisely known vaccination coverage 
mean rates for the patients-resi- 
dents, the elderly and the medical 
staff are higher than the rates 
given when they are estimated. 
Overall, Swiss immunization rates 
are generally well below those of 
other European countries and the 
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United States. The SFOPH recom- 
mends the vaccination for specific 
risk groups but each canton is 
free to decide whether to organize 
the promotion locally. Cultural dif- 
ferences appear to play an im- 
portant role with regard to the 
perception of influenza vaccination 
programmes and their promotion 
and monitoring, as shown by the 
differences in immunization rates 
in the French, Italian and German 
speaking regions. The question 
arises whether vaccination pro- 
grammes should continue to be 
delegated to the cantons but with 
an increased assistance and sup- 
port by the federal health author- 
ities, or be better conducted en- 
tirely by the SFOPH with a pro- 
motion adapted to the local sen- 
sibilities and cultural identities 
within the country. Both options 
would increase protection against 
influenza and achieve a better 
cultural balance in the promotion 
of this important preventive inter- 
vention. 
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